In melittin-treated tumor cells, we observed a significant increase in the expression levels of Bax, Cytochrome C, AIF, Endo G, and Smac/Diablo, accompanied by a notable decrease in Bcl-2 expression (Figure 4C). The gene discussed is AIFM1; the disease is neoplasm.